hsil
Showing 1 - 25 of 119
Vulvar HSIL, HPV Trial in Rotterdam (Gardasil 9 Suspension for Injection, Placebo)
Not yet recruiting
- Vulvar HSIL
- HPV
- Gardasil 9 Suspension for Injection
- Placebo
-
Rotterdam, NetherlandsErasmus MC
Sep 21, 2023
Vulvar Diseases, HPV Infection, Vulvar HSIL Trial in Cleveland, Mayfield Heights (Artesunate ointment, Placebo ointment)
Not yet recruiting
- Vulvar Diseases
- +12 more
- Artesunate ointment
- Placebo ointment
-
Cleveland, Ohio
- +2 more
Oct 4, 2023
Prognostic Study of HPV Virus Integration in Women With HSIL
Recruiting
- HPV Infection
- +2 more
- Follow up
-
Fuzhou, Fujian, China
- +12 more
Feb 16, 2023
ANAL PRECANCEROUS LESIONS IN HIGH-RISK PATIENTS.
Recruiting
- AIN3
- +2 more
- Detection of anal HSIL in a routine colonoscopy.
-
Gondomar, Porto, PortugalFernando Pessoa Teaching Hospital
Dec 9, 2022
Vulvar Dysplasia, HPV-Related Vulvar Intraepithelial Neoplasia, Preinvasive Vulvar Disease Trial in Baltimore, Cleveland,
Active, not recruiting
- Vulvar Dysplasia
- +4 more
- artesunate ointment 40%
-
Baltimore, Maryland
- +3 more
Oct 31, 2022
HPV Integration Trial in Wuhan (HPV integration test)
Recruiting
- HPV Integration
- HPV integration test
-
Wuhan, Hubei, ChinaTongji Hospital affiliated to Tongji Medical College of Huazhong
Mar 18, 2022
Anal High Grade Squamous Intraepithelial Lesion, Anal Precancerous Condition, AIN 2/3 Trial in San Francisco, Chicago, New York
Not yet recruiting
- Anal High Grade Squamous Intraepithelial Lesion
- +5 more
- Artesunate
- Placebo
-
San Francisco, California
- +2 more
Nov 7, 2022
Education, Medical Trial (Enhanced Training on screening and treatment of HSIL (e-STH))
Not yet recruiting
- Education, Medical
- Enhanced Training on screening and treatment of HSIL (e-STH)
- (no location specified)
Apr 4, 2023
COrSIcA: Disease Measurement
Not yet recruiting
- Anal Intraepithelial Neoplasia
- +2 more
- Physical examination
- (no location specified)
May 4, 2023
Anal Intraepithelial Neoplasia, Anal Cancer, Human Papilloma Virus Trial in Vancouver, Ottawa, Toronto (9-valent HPV
Not yet recruiting
- Anal Intraepithelial Neoplasia
- +2 more
- 9-valent HPV vaccination
-
Vancouver, British Columbia, Canada
- +3 more
Jun 9, 2022
HSIL of Cervix Trial in Heze (NWRD08)
Recruiting
- HSIL of Cervix
- NWRD08
-
Heze, Shandong, ChinaHeze Municipal Hospital
Jun 6, 2023
HPV Infection, HSIL, High-Grade Squamous Intraepithelial Lesions, Viral Load Trial in China (Follow-up)
Recruiting
- HPV Infection
- +2 more
- Follow-up
-
Fuzhou, Fujian, China
- +9 more
Mar 7, 2022
Magnetic Resonance Imaging Examination Trial in Wenzhou (MRI,SCC-Ag)
Recruiting
- Magnetic Resonance Imaging Examination
- MRI,SCC-Ag
-
Wenzhou, Zhejiang, ChinaThe 2nd Affiliated Hospital and Yuying Children's Hospital of WM
Aug 3, 2022
High Grade Squamous Intra-epithelial Lesion (HSIL) Trial in Darlinghurst (Pomalidomide 2 MG Oral Capsule [Pomalyst])
Active, not recruiting
- High Grade Squamous Intra-epithelial Lesion (HSIL)
- Pomalidomide 2 MG Oral Capsule [Pomalyst]
-
Darlinghurst, New South Wales, AustraliaSt Vincent's Hospital
Mar 28, 2022
Anal Tumor Trial in Chicago, New York, Québec (VGX-3100, CELLECTRA™ 5PSP)
Completed
- Anal Neoplasm
- VGX-3100
- CELLECTRA™ 5PSP
-
Chicago, Illinois
- +2 more
Dec 6, 2021
In Era of HPV Vaccine, What Are The Current HPV Subtypes
Recruiting
- HSIL, High-Grade Squamous Intraepithelial Lesions
- +2 more
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Sep 21, 2021
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL), Vulvar Dysplasia, Vulvar Intraepithelial Neoplasia (VIN) Trial in
Completed
- Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
- +6 more
- VGX-3100
- +2 more
-
Newark, Delaware
- +14 more
Dec 6, 2021
Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, HSIL Trial in Worldwide (VGX-3100, Placebo,
Completed
- Cervical Dysplasia
- +2 more
- VGX-3100
- +2 more
-
Tucson, Arizona
- +52 more
Oct 13, 2022
Diagnoses Disease, Screening, HSIL of Cervix Trial in Brazil (Endocervical liquid-base cytology, Endocervical cell block,
Recruiting
- Diagnoses Disease
- +3 more
- Endocervical liquid-base cytology
- +2 more
-
Campo Grande, Mato Grosso Do Sul, Brazil
- +3 more
Nov 2, 2021
Squamous Lntraepithelial Lesions of Vulva, Tumors, Squamous Cell, Vulvar HSIL Trial run by the NCI (E7 T Cell Receptor (TCR))
Terminated
- Squamous Lntraepithelial Lesions of Vulva
- +2 more
- E7 T Cell Receptor (TCR)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 18, 2021
HSIL in Patients With Future Pregnancy Aspiration
Recruiting
- Cervical Intraepithelial Neoplasia
- +2 more
- Conservative management with regular follow-up
- Conization
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Mar 4, 2021
HSIL of Cervix, HSIL, High Grade Squamous Intraepithelial Lesions, High-Grade Cervical Intraepithelial Neoplasia Trial in
Completed
- HSIL of Cervix
- +8 more
- Topical ABI-1968
-
Bloemfontein, Free State Province, South AfricaResearch Center
Jan 11, 2021
Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, HSIL Trial in Worldwide (VGX-3100, Placebo,
Completed
- Cervical Dysplasia
- +2 more
- VGX-3100
- +2 more
-
Mesa, Arizona
- +59 more
Dec 6, 2021
HPV Integration on Prognosis of Young Women With CIN2 in China
Recruiting
- Cervical Intraepithelial Neoplasia
- +3 more
- Follow up
-
Fuzhou, Fujian, China
- +10 more
Mar 7, 2022